U.S. Paper and Forestry Products Stock News

NasdaqGS:BSP
NasdaqGS:BSPSoftware

Is Bending Spoons’ (BSP) Madrid Push Quietly Redefining Its European Talent and Innovation Strategy?

Bending Spoons has recently opened a new office in Madrid’s Recoletos district, its third European base after Milan and London, while offering extensive relocation and commuting support, and actively engaging Spain’s tech community through events, competitions, and scholarships worth more than €1.00 billion across Europe in 2026. By pairing physical expansion in Madrid with large-scale talent initiatives such as the First Ascent Spain retreat and nationwide programming contests, Bending...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Strategic Education (STRA) Could Be 14% Undervalued On Strong Quarterly Results

Why Strategic Education stock is back in focus after its latest quarterly update Strategic Education (STRA) is back on investor radars after reporting higher second quarter and first half 2026 sales and net income, alongside record employer enrollment and margin expansion. See our latest analysis for Strategic Education. The latest earnings, buyback activity and affirmed dividend appear to have supported sentiment around Strategic Education, with the share price at $84.88 and a 90 day share...
NYSE:UHS
NYSE:UHSHealthcare

The Bull Case For Universal Health Services (UHS) Could Change Following Big Q2 Earnings Beat And Buyback Completion - Learn Why

Universal Health Services recently reported past second-quarter 2026 results showing higher sales of US$4,638.01 million and net income of US$358.45 million, and disclosed that between April 1 and June 30, 2026 it repurchased 1,890,000 shares for US$320.3 million. These results also mark the completion of a long-running buyback program totaling about US$6.62 billion and reducing the share count by very large percentage levels, which can meaningfully influence per-share metrics and capital...
NasdaqGS:REPL
NasdaqGS:REPLBiotechs

Replimune Group (REPL) Wins FDA Approval, Is The Valuation Still Too Rich?

Replimune Group (REPL) stock is back in focus after Robbins LLP announced a securities class action tied to the company’s RP1 melanoma program and the U.S. Food and Drug Administration’s April 2026 Complete Response Letter. See our latest analysis for Replimune Group. Investors have been weighing the legal overhang from the RP1 class action against fresh momentum after the FDA granted accelerated approval for TUDRIQEV, with Replimune Group’s share price at $12.06 reflecting a 90 day share...
NYSE:TPC
NYSE:TPCConstruction

Tutor Perini (TPC) Posts Strong Q2 Growth, Is The Stock Still Cheap?

Tutor Perini (TPC) just delivered a busy Q2 2026, with higher revenue and net income, a larger quarterly dividend, active share repurchases, and a new federal infrastructure contract that together drew fresh attention to the stock. See our latest analysis for Tutor Perini. The strong Q2 results, larger dividend, new federal contract and ongoing buybacks have arrived alongside sharp share price momentum for Tutor Perini, with a 30.60% 1 month share price return and a 42.91% year to date share...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Is NVIDIA (NVDA) Still Below Fair Value Following Fresh AI Infrastructure Demand?

NVIDIA (NVDA) is back in focus after Zayo Group announced plans to build more than 8,000 miles of new long-haul fiber using NVIDIA AI infrastructure, a move aimed at supporting expanding AI data traffic. See our latest analysis for NVIDIA. All of this AI infrastructure news around NVIDIA arrives while momentum in the stock has picked up again, with a 7 day share price return of 11.56% and a year to date share price return of 18.59%, set against a very large 5 year total shareholder return. If...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Five9 (FIVN) Lifts AI Outlook And Wins New Contract, Is The Stock Now Expensive?

Five9 earnings and AI contract put recent moves in context Five9 (FIVN) just reported second quarter 2026 results with higher sales and net income than a year earlier, supported by faster AI related revenue and a new Fortune 100 contract. The company also issued guidance for the third quarter and full year 2026, introduced next generation voice AI agents and was recently added to several S&P indices, giving investors several fresh data points to evaluate. See our latest analysis for...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Are ADI’s AI Bets And Supply Resilience Quietly Redefining Its Multi-Year Earnings Story?

In recent days, analysts have reiterated broadly positive views on Analog Devices, citing strong earnings expectations, upbeat brokerage ratings, and growing confidence reflected in a Zacks Rank #2 (Buy). What stands out is how Analog Devices’ AI-focused investments, supply chain resilience, and software initiatives have become central to analyst optimism about its earnings outlook. We’ll now examine how Analog Devices’ intensified AI initiatives ahead of earnings may influence the...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian Automotive (RIVN) Could Be 15% Undervalued As Earnings Show Narrowing Losses

Rivian Automotive (RIVN) is back in focus after its second quarter 2026 earnings update, which showed higher sales and revenue year over year, along with a narrower net loss and reduced loss per share. See our latest analysis for Rivian Automotive. Rivian Automotive’s 4.03% 1 day share price return and 5.12% 7 day share price return around the earnings release contrast with a weaker year to date share price return, while the 1 year total shareholder return of 35.71% indicates a shift in...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Is Dave (DAVE) Cheap As Raised 2026 Outlook And Buyback Refocus Valuation?

Dave (DAVE) moved back into focus after its early August earnings update, which paired higher reported revenue with a dip in quarterly net income, a raised 2026 revenue outlook, and completion of a sizable buyback. See our latest analysis for Dave. The Q2 update and raised 2026 revenue outlook came alongside a sharp reset in Dave’s share price. The stock is down 12.96% on a 1 day basis and 20.67% over 30 days, yet still carries a 44.86% year to date share price return and a 1 year total...
NYSE:GEF
NYSE:GEFPackaging

Should Greif’s Higher Q3 Earnings and Polymer Bolt‑On Focus Prompt Action From GEF Investors?

In the third quarter of 2026, Greif, Inc. reported higher sales of US$1,165.6 million and net income of US$77.8 million, while updating that one long-running repurchase program dating back to 2005 has now reached 5,674,369 shares for US$360.48 million and a newer 2026 authorization saw no buybacks in the latest quarter. Management also confirmed on the recent earnings call that Greif is prioritizing organic growth supported by recurring bolt-on acquisitions in advanced polymer packaging,...
NYSE:LH
NYSE:LHHealthcare

What Labcorp Holdings (LH)'s New PTEN Test and Guidance Hike Means For Shareholders

In early August 2026, Labcorp announced nationwide availability of Roche's FDA-approved VENTANA PTEN (SP218) RxDx Assay for identifying PTEN protein loss in prostate cancer, alongside reporting higher quarterly sales and earnings and modestly raising its full-year 2026 revenue growth guidance. This combination of expanding precision oncology capabilities and improved financial performance highlights how Labcorp is deepening its role in personalized cancer care while reinforcing its core...
NYSE:INGR
NYSE:INGRFood

Ingredion (INGR) Reaffirmed Its 2026 Guidance, Is The Stock Fully Valued?

Why Ingredion stock is back in focus after fresh guidance Ingredion (INGR) put out second quarter 2026 results alongside new third quarter guidance and a reaffirmed full year outlook, giving investors updated figures on sales, earnings and profitability. The company now expects third quarter net sales to be up low single digits compared with a year earlier, with full year 2026 sales projected to be flat to up low single digits and reported EPS guided to a range of $9.15 to $9.75. Management...